Addressing the Need for Alzheimer’s Research
Diagnostics and Procedures Should you think about taking part in a clinical trial? Alzheimer’s is a triple threat with soaring prevalence, no cure and enormous cost burdens.
Alzheimer’s is a triple threat unlike any other, with soaring prevalence, no treatment and an enormous cost. Of the top causes of death in America, Alzheimer’s is the only one on the rise—and the only one that we have no way to prevent, cure or effectively treat.
However, real progress is being made, as more and more Americans speak out about this dreadful disease.
To stop Alzheimer’s, we need more private and public research funding, faster clinical trials, new regulatory approaches, innovation-friendly reimbursement and earlier detection and diagnosis. So, what can each of us do?
Tell Congress to prioritize Alzheimer’s research.
Despite the urgent need, federal Alzheimer’s research funding is just $586 million annually—far less than for other diseases and a fraction the $2 billion scientific experts say is needed. Alzheimer’s is 100 percent lethal, yet lags in research investment.
Register for an Alzheimer’s clinical trial.
Alzheimer’s research is frustratingly slow because scientists have difficulty finding people for research studies. African Americans and Latinos are particularly needed. Healthy volunteers, too.
Nearly two-thirds of Americans have known someone with Alzheimer’s or memory loss, yet many hesitate to share their story, often out of concern for the dignity of their loved one. It’s time we bring Alzheimer’s out of the shadows and into the national spotlight.
Donate to an Alzheimer’s-serving organization seeking to change the trajectory of this disease.
Working together, we can stop Alzheimer’s.